Kimia Biosciences Completes Major Board Restructuring with New Appointments
Kimia Biosciences Limited completed a major board restructuring on April 04, 2026, appointing two new independent directors and a new Company Secretary while reconstituting all board committees. The changes follow the resignation of the previous Company Secretary and completion of an independent director's tenure.
*this image is generated using AI for illustrative purposes only.
Kimia Biosciences Limited has announced significant changes to its board composition and key managerial positions following a board meeting held on April 04, 2026, marking a comprehensive restructuring of the pharmaceutical company's leadership.
New Independent Directors Appointed
The board has appointed two new Additional Directors in the category of Non-Executive Independent Directors, both effective from April 04, 2026, for a term of five years, subject to shareholder approval.
| Parameter | Mr. Avinash Prabhat | Ms. Reema Goyal |
|---|---|---|
| DIN | 10997441 | 11266730 |
| Age | 30 years | 31 years |
| Qualification | Company Secretary, B.Com | Company Secretary in Practice, B.Com |
| Experience | 5+ years in Corporate Law, SEBI Laws | 5+ years in Corporate Law, SEBI Laws |
| Current Role | Independent Director at Cranex Limited | Professional Director at InfosPire CompLAWiance Advisory |
| Shareholding | Nil | Nil |
Key Managerial Personnel Changes
Following the resignation of Pallavi Garg (ACS 69848) as Company Secretary & Compliance Officer on April 03, 2026, the board has appointed Mr. Abhishek Kumar Pandey (M. No. F12457) to the position effective April 04, 2026.
| Parameter | Details |
|---|---|
| Name | Mr. Abhishek Kumar Pandey |
| Membership Number | F12457 |
| Position | Company Secretary & Compliance Officer |
| Appointment Date | April 04, 2026 |
| Experience | 10+ years in SEBI, LODR, Corporate Laws |
| Qualification | ICSI Member since 2012, Law Graduate |
| Contact Email | Compliance.kimiabiosciences@gmail.com |
| Contact Number | 7678388892 |
Board Committee Reconstitution
The company has reconstituted all major board committees with the new appointments. The restructured committees include Audit Committee, Nomination & Remuneration Committee, Stakeholders Relationship Committee, and Corporate Social Responsibility Committee, all comprising Sameer Goel (Executive Director), Avinash Prabhat (Independent Director), and Reema Goyal (Independent Woman Director).
Director Cessation
The board noted the completion of tenure of Mr. Jagdeep Dhawan (DIN: 00778235) as Independent Director, who ceased to hold office on March 28, 2026, following the completion of his 10-year tenure as Independent Director.
Regulatory Compliance
All appointments and changes have been made in compliance with Regulation 30 of SEBI (LODR) Regulations, 2015, and SEBI Master Circular dated January 30, 2026. The board meeting commenced at 4:30 p.m. and concluded at 5:00 p.m., with Managing Director & CEO Sameer Goel (DIN: 00161786) overseeing the proceedings.
Historical Stock Returns for Kimia Biosciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.49% | +6.16% | +42.86% | +20.26% | -7.69% | -17.53% |
What strategic initiatives might Kimia Biosciences pursue with its newly restructured leadership team in the pharmaceutical sector?
How could the appointment of relatively young independent directors (ages 30-31) impact the company's governance approach and decision-making processes?
Will the comprehensive board restructuring signal potential changes in Kimia Biosciences' business strategy or operational focus areas?
16
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
